News | July 29, 2022
Alniche Lifesciences celebrates 15 anniversary
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
Syngene's collaboration with Zoetis started in 2011
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
Aurobindo Pharma Foundation endeavours to make a positive contribution to the underprivileged ommunities by supporting a wide range of socio-economic, educational, and health initiatives.
The company is now introducing the product into the India pharmaceutical market.
The company also raised Rs 270 crore investment from Temasek in 2019
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
The plant is expected to start commercial operations from Q4FY24
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
Subscribe To Our Newsletter & Stay Updated
